PsyBio Therapeutics Corp. News Releases

PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale

Fri, 21 Jul 2023 08:00:00 -0400

PsyBio continues to develop psycho-targeted, biosynthesized tryptamines and with this authorization becomes the first biotechnology company to obtain government sanctioned, formal, written authorization to manufacture biosynthetic tryptamines including PsyBio-11142 at scale Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - July 21, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon...

PsyBio Announces Closing of Third Tranche of Private Placement

Thu, 20 Apr 2023 17:36:00 -0400

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - April 20, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon discovery and development of novel psycho-targeted therapeutics being designed to improve mental health and neurological conditions, is pleased to announce that the Company has completed the third tranche of its previously announced non-brokered private placement offering of...

PsyBio Announces Panel Participation on NextGen Psychedelics at Benzinga Cannabis Capital Conference

Thu, 06 Apr 2023 09:12:00 -0400

Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - April 6, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon discovery and development of novel psycho-targeted therapeutics being designed to improve mental health and neurological conditions, is pleased to announce that PsyBio CEO Evan Levine will be participating on the panel NextGen Psychedelics and conducting one-on-one meetings, at...

PsyBio Therapeutics Founder Wins Best Pitch at Investment Summit

Mon, 13 Mar 2023 07:00:00 -0400

Prestigious award recognizes innovative company as a leading player in the emerging field of psychedelic medicine Miami, Florida--(Newsfile Corp. - March 13, 2023) - Evan Levine, CEO and Founder of PsyBio Therapeutics, won Best Pitch at Kahner Global's Cannabis & Psychedelics Investment Summit last week. Levine was awarded for his visionary approach to developing next-generation therapies for mental health conditions using cutting-edge research and development methods.The Summit is an annual...